chr20-46726312-G-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_030777.4(SLC2A10):c.1276G>T(p.Gly426Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000205 in 1,609,532 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_030777.4 missense
Scores
Clinical Significance
Conservation
Publications
- arterial tortuosity syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_030777.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC2A10 | NM_030777.4 | MANE Select | c.1276G>T | p.Gly426Trp | missense | Exon 2 of 5 | NP_110404.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC2A10 | ENST00000359271.4 | TSL:1 MANE Select | c.1276G>T | p.Gly426Trp | missense | Exon 2 of 5 | ENSP00000352216.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152206Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000410 AC: 1AN: 243884 AF XY: 0.00000754 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1457326Hom.: 0 Cov.: 33 AF XY: 0.0000207 AC XY: 15AN XY: 725160 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74366 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Arterial tortuosity syndrome Pathogenic:5Other:1
ACMG categories: PM1,PM2,PP3,PP5
This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 426 of the SLC2A10 protein (p.Gly426Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with arterial tortuosity syndrome and/or thoracic aortic aneurysm (PMID: 17935213, 29907982). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4589). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC2A10 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
The p.Gly426Trp variant in SLC2A10 has been reported in 3 compound heterozygous and 1 homozygous individuals with arterial tortuosity syndrome (Callewaert 2008, Overwater 2018). It has also been identified in 1/110674 European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 4589). Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. This variant is located in the TMD10 functional domain of the SLC2A10 gene (Callewaert 2008). In summary, this variant meets criteria to be classified as likely pathogenic for autosomal recessive arterial tortuosity syndrome. ACMG/AMP Criteria applied: PM2, PP3, PM3_Strong.
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
The p.G426W pathogenic mutation (also known as c.1276G>T), located in coding exon 2 of the SLC2A10 gene, results from a G to T substitution at nucleotide position 1276. The glycine at codon 426 is replaced by tryptophan, an amino acid with highly dissimilar properties. This variant has been detected in three probands with arterial tortuosity syndrome (ATS) who also had a second SLC2A10 variant in trans, one of which was a frameshift alteration (Callewaert BL et al. Hum. Mutat., 2008 Jan;29:150-8). This variant has also been detected in the homozygous state in a pediatric proband with features consistent with ATS (Overwater E et al. Hum. Mutat., 2018 09;39:1173-1192). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30090112, 17935213, 35186825, 29907982)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at